Linear and nonlinear relationships between cognitive subdomains of ability discrepancy and Alzheimer's disease biomarkers.
| Autor: | McDonough IM; Department of Psychology, The University of Alabama., Popp TE; Department of Psychology, The University of Alabama. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Neuropsychology [Neuropsychology] 2020 Feb; Vol. 34 (2), pp. 211-226. Date of Electronic Publication: 2019 Dec 02. |
| DOI: | 10.1037/neu0000606 |
| Abstrakt: | Objective: Substantial research indicates that fluid and crystallized abilities are highly correlated throughout the adult life span. However, recent proposals suggest that a large discrepancy between these two abilities, defined as crystallized performance minus fluid performance, indicates heightened risk for Alzheimer's disease (AD). Method: In 266 cognitively healthy older adults, the present study tested linear and quadratic relationships between an ability discrepancy score and early AD neuropathology indexed via in vivo measures of beta-amyloid deposition and cortical thickness in AD-vulnerable regions. We also tested the extent that alternative forms of this ability discrepancy measure (e.g., subdomain discrepancies, verbal-visual discrepancies) and an episodic memory composite might also be sensitive markers of early AD pathology. Results: An overall ability discrepancy was linearly and positively correlated with beta- amyloid. A quadratic relationship was found between the overall ability discrepancy score and cortical thickness such that a small positive correlation was found at lower discrepancy levels (fluid > crystallized), but at higher discrepancy levels (crystallized > fluid) a negative relationship was found (i.e., an inverted-U pattern). Similar patterns were found across each subdomain of cognition, but the effects were weaker than the overall ability discrepancy score. Importantly, inclusion of episodic memory (the gold standard) did not alter any of the effects, suggesting that an ability discrepancy confers unique predictiveness of AD biomarkers. Conclusions: These findings replicate previous findings and increase the confidence in their usefulness to predict AD biomarkers. Longitudinal validation is needed to clearly relate an ability discrepancy to specific stages of preclinical AD. (PsycINFO Database Record (c) 2020 APA, all rights reserved). |
| Databáze: | MEDLINE |
| Externí odkaz: |
|